Document:

<PAGE>

                                                                    EXHIBIT 4.13

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE
HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO
SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A
REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN
"ACCREDITED INVESTOR" AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT SECURED
BY SUCH SECURITIES.

THE TRANSFER OF THIS WARRANT IS RESTRICTED AS DESCRIBED HEREIN.

                           SYNTAX-BRILLIAN CORPORATION

                                     Warrant
                   for the Purchase of Shares of Common Stock
                          (par value $0.001 per share)

No. ______                                                        ______ Shares

      THIS CERTIFIES that, for value received, _____________, whose address is
_________________________ (together with any person or entity to which this
Warrant (or any portion hereof) may be transferred, the "Holder"), is entitled
to subscribe for and purchase from Syntax-Brillian Corporation, a Delaware
corporation (the "Company"), upon the terms and conditions set forth herein,
______ shares of the Company's common stock, par value $0.001 per share ("Common
Stock"), at a price of $5.00 per share (subject to adjustment as set forth
herein, the "Exercise Price"). As used herein the term "Warrant" shall mean and
include this Warrant and any Common Stock or warrants hereafter issued as a
consequence of the exercise or transfer of this Warrant in whole or in part.

                                       1

<PAGE>

      The number of shares of Common Stock issuable upon exercise of the
Warrants (the "Warrant Shares") and the Exercise Price may be adjusted from time
to time as hereinafter set forth. The Warrant Shares are entitled to the
benefits, and subject to the obligations, set forth in (i) the Registration
Rights Agreement among the Company, the Holder and certain other parties dated
concurrently herewith (the "Registration Rights Agreement"), and (ii) the
Securities Purchase Agreement among the Company, the Holder and certain other
parties dated concurrently herewith (the "Purchase Agreement").

      1. Exercise Period. This Warrant may be exercised at any time or from time
to time during the period commencing at 10:00 A.M. Pacific Time on December __,
2005, and ending at 5:00 P.M. Pacific Time on December __, 2010 (the "Exercise
Period").

      2. Procedure for Exercise; Effect of Exercise.

            (a) Cash Exercise. This Warrant may be exercised, in whole or in
part, by the Holder during normal business hours on any business day during the
Exercise Period by (i) the presentation and surrender of this Warrant to the
Company at its principal executive office along with a duly executed Notice of
Exercise (in the form attached hereto) specifying the number of Warrant Shares
to be purchased, and (ii) delivery of payment to the Company of the Exercise
Price for the number of Warrant Shares specified in the Notice of Exercise by
cash, wire transfer of immediately available funds to a bank account specified
by the Company, or by certified or bank cashier's check.

            (b) Cashless Exercise. This Warrant may also be exercised by the
Holder through a cashless exercise, as described in this Section 2(b). In such
case, this Warrant may be exercised, in whole or in part, by the Holder during
normal business hours on any business day during the Exercise Period by the
presentation and surrender of this Warrant to the Company at its principal
office along with a duly executed Notice of Exercise specifying the number of
Warrant Shares to be applied to such exercise. The number of shares of Common
Stock to be issued upon exercise of this Warrant pursuant to this Section 2(b)
shall equal the value of this Warrant (or the portion thereof being canceled)
computed as of the date of delivery of this Warrant to the Company using the
following formula:

            X =    Y(A-B)
                   ------
                     A

     Where:

            X = the number of shares of Common Stock to be issued to Holder
                under this Section 2(b);

            Y = the number of Warrant Shares identified in the Notice of
                Exercise as being applied to the subject exercise;

            A = the Current Market Price on such date; and

            B = the Exercise Price on such date

For purposes of this Section 2(b), Current Market Price shall have the
definition provided in Section 6(g).

                                       2

<PAGE>

      The Company acknowledges and agrees that this Warrant was issued on the
date set forth at the end of this Warrant. Consequently, the Company
acknowledges and agrees that, if the Holder conducts a cashless exercise
pursuant to this Section 2(b), the period during which the Holder held this
Warrant may, for purposes of Rule 144 promulgated under the Securities Act of
1933, as amended (the "Securities Act"), be "tacked" to the period during which
the Holder holds the Warrant Shares received upon such cashless exercise.

      Notwithstanding the foregoing, the Holder may conduct a cashless exercise
pursuant to this Section 2(b) only after the first anniversary of the initial
issuance date of this Warrant, and then only in the event that a registration
statement covering the resale of the Warrant Shares is not then effective at the
time that the Holder wishes to conduct such cashless exercise.

            (c) Company's Response; Effect of Exercise. Upon receipt by the
Company of a copy of a Notice of Exercise (including a copy received via
facsimile), the Company shall immediately send to the Holder, via facsimile, a
confirmation of receipt of such Notice of Exercise. Upon receipt by the Company
of this Warrant and the original Notice of Exercise, together with proper
payment of the Exercise Price, as provided in this Section 2, the Company or its
designated transfer agent (the "Transfer Agent"), as applicable, shall, within
three (3) business days following the date of receipt by the Company of the
original Notice of Exercise (so long as this Warrant and the proper payment of
the Exercise Price are received by the Company on or before such third business
day), issue and deliver to the Depository Trust Company ("DTC") account on the
Holder's behalf via the Deposit Withdrawal Agent Commission System ("DWAC") as
specified in the Notice of Exercise, registered in the name of the Holder or its
designee, for the number of shares of Common Stock to which the Holder shall be
entitled. Notwithstanding the foregoing to the contrary, the Company or its
Transfer Agent shall only be obligated to issue and deliver the shares to the
DTC on the Holder's behalf via DWAC if (A) a registration statement covering the
resale of the Warrant Shares has been declared effective by the Securities and
Exchange Commission, (B) the exercise of this Warrant is in connection with a
sale, and (C) the Holder has complied with the applicable prospectus delivery
requirements. If this Warrant should be exercised in part only, the Company
shall, upon surrender of this Warrant for cancellation, execute and deliver a
new Warrant evidencing the right of the Holder to purchase the balance of the
Warrant Shares subject to purchase hereunder. Upon receipt by the Company of
this Warrant and a Notice of Exercise, together with proper payment of the
Exercise Price, as provided in this Section 2, the Company agrees that such
Warrant Shares shall be deemed to be issued to the Holder as the record holder
of such Warrant Shares as of the close of business on the date on which this
Warrant has been surrendered and payment has been made for such Warrant Shares
in accordance with this Warrant and the Holder shall be deemed to be the holder
of record of the Warrant Shares, notwithstanding that the stock transfer books
of the Company shall then be closed or that certificates representing such
Warrant Shares shall not then be actually delivered to the Holder.

      3. Registration of Warrants; Transfer of Warrants. Any Warrants issued
upon the transfer or exercise in part of this Warrant shall be numbered and
shall be registered in a warrant register as they are issued. The Company shall
be entitled to treat the registered holder of any Warrant on the warrant
register as the owner in fact thereof for all purposes and shall not be bound to
recognize any equitable or other claim to or interest in such Warrant on the
part of

                                       3

<PAGE>

any other person, and shall not be liable for any registration or transfer of
Warrants which are registered or to be registered in the name of a fiduciary or
the nominee of a fiduciary unless made with the actual knowledge that a
fiduciary or nominee is committing a breach of trust in requesting such
registration or transfer, or with the knowledge of such facts that its
participation therein amounts to bad faith. This Warrant shall be transferable
only on the books of the Company upon delivery thereof duly endorsed by the
Holder or by its duly authorized attorney or representative, or accompanied by
proper evidence of succession, assignment, or authority to transfer. In all
cases of transfer by an attorney, executor, administrator, guardian, or other
legal representative, duly authenticated evidence of his or its authority shall
be produced. Upon any registration of transfer, the Company shall deliver a new
Warrant or Warrants to the person entitled thereto. This Warrant may be
exchanged, at the option of the Holder thereof, for another Warrant, or other
Warrants of different denominations, of like tenor and representing in the
aggregate the right to purchase a like number of Warrant Shares, upon surrender
to the Company or its duly authorized agent.

      4. Restrictions on Transfer. (a) The Holder, as of the date of issuance
hereof, represents to the Company that such Holder is acquiring the Warrants for
its own account and not with a view to the distribution thereof or of the
Warrant Shares. Notwithstanding any provisions contained in this Warrant to the
contrary, this Warrant and the related Warrant Shares shall not be transferable
except pursuant to the proviso contained in the following sentence or upon the
conditions specified in this Section 4, which conditions are intended, among
other things, to insure compliance with the provisions of the Securities Act and
applicable state law in respect of the transfer of this Warrant or such Warrant
Shares. The Holder by acceptance of this Warrant agrees that the Holder will not
transfer this Warrant or the related Warrant Shares prior to delivery to the
Company of an opinion of the Holder's counsel (as such opinion and such counsel
are described in Section 4(b) hereof) or until registration of such Warrant
Shares under the Securities Act has become effective or after a sale of such
Warrant or Warrant Shares has been consummated pursuant to Rule 144 or Rule 144A
under the Securities Act; provided, however, that the Holder may freely transfer
this Warrant or such Warrant Shares (without delivery to the Company of an
opinion of counsel) (i) to one of its nominees, affiliates or a nominee thereof,
(ii) to a pension or profit-sharing fund established and maintained for its
employees or for the employees of any affiliate, (iii) from a nominee to any of
the aforementioned persons as beneficial owner of this Warrant or such Warrant
Shares, (iv) to a qualified institutional buyer, so long as such transfer is
effected in compliance with Rule 144A under the Securities Act, or (v) to an
accredited investor (as such term is defined in Regulation D under the
Securities Act).

            (b) The Holder, by its acceptance hereof, agrees that prior to any
transfer of this Warrant or of the related Warrant Shares (other than as
permitted by Section 4(a) hereof or pursuant to a registration under the
Securities Act), the Holder will give written notice to the Company of its
intention to effect such transfer, together with an opinion of such counsel for
the Holder in form reasonably acceptable to the Company, to the effect that the
proposed transfer of this Warrant and/or such Warrant Shares may be effected
without registration under the Securities Act. Upon delivery of such notice and
opinion to the Company, the Holder shall be entitled to transfer this Warrant
and/or such Warrant Shares in accordance with the intended method of disposition
specified in the notice to the Company.

                                       4

<PAGE>

            (c) Each stock certificate representing Warrant Shares issued upon
exercise or exchange of this Warrant shall bear the following legend unless the
opinion of counsel referred to in Section 4(b) states such legend is not
required:

      "THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
      WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
      OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND,
      ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
      REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
      AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
      REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF
      COUNSEL TO THE TRANSFEROR TO SUCH EFFECT. SUCH SECURITIES MAY BE PLEDGED
      IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED
      BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN
      "ACCREDITED INVESTOR" AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT."

The Holder understands that the Company may place, and may instruct any transfer
agent or depository for the Warrant Shares to place, a stop transfer notation in
the securities records in respect of the Warrant Shares.

      5. Reservation of Shares. The Company shall at all times during the
Exercise Period reserve and keep available out of its authorized and unissued
Common Stock, solely for the purpose of providing for the exercise of the rights
to purchase all Warrant Shares granted pursuant to the Warrants, such number of
shares of Common Stock as shall, from time to time, be sufficient therefor. The
Company covenants that all shares of Common Stock issuable upon exercise of this
Warrant, upon receipt by the Company of the full Exercise Price therefor, and
all shares of Common Stock issuable upon conversion of this Warrant, shall be
validly issued, fully paid, non-assessable, and free of preemptive rights, and
free from all taxes, claims, liens, charges and other encumbrances.

      6. Exercise Price Adjustments. The Exercise Price shall be subject to
adjustment from time to time as follows:

            (a) (i) In the event that the Company shall (A) pay a dividend or
make a distribution, in shares of Common Stock, on any class of capital stock of
the Company or any subsidiary which is not directly or indirectly wholly owned
by the Company, (B) split or subdivide its outstanding Common Stock into a
greater number of shares, or (C) combine its outstanding Common Stock into a
smaller number of shares, then in each such case the Exercise Price in effect
immediately prior thereto shall be adjusted so that the Holder of this Warrant
thereafter surrendered for exercise shall be entitled to receive the number of
shares of Common Stock that such Holder would have owned or have been entitled
to receive after the occurrence of any of the events described above had this
Warrant been exercised immediately prior to the

                                       5

<PAGE>

occurrence of such event. An adjustment made pursuant to this paragraph 6(a)(i)
shall become effective immediately after the close of business on the record
date in the case of a dividend or distribution (except as provided in paragraph
6(f) below) and shall become effective immediately after the close of business
on the effective date in the case of such subdivision, split or combination, as
the case may be. Any shares of Common Stock issuable in payment of a dividend
shall be deemed to have been issued immediately prior to the close of business
on the record date for such dividend for purposes of calculating the number of
outstanding shares of Common Stock under clause (ii) below.

               (ii) In the event that the Company shall issue or distribute any
Common Stock or preferred stock, whether or not authorized on the date hereof,
and rights, options or warrants to purchase Common Stock or preferred stock and
securities of any type whatsoever that are, or may become, convertible into
Common Stock or preferred stock ("New Securities"), in any such case at a price
per share less than $5.00 or that would entitle the holders of the New
Securities to subscribe for or purchase shares of Common Stock at less than
$5.00 per share (provided that the issuance of Common Stock upon the exercise of
New Securities that are rights, warrants, options or convertible or exchangeable
securities ("New Derivative Securities") will not cause an adjustment in the
Exercise Price if no such adjustment would have been required at the time such
New Derivative Security was issued), then the Exercise Price in effect
immediately prior thereto shall be adjusted so that the Exercise Price shall
equal the price at which the Company issues or distributes such New Securities
(or the price at which the holders of the New Securities are entitled to
subscribe for or purchase shares of Common Stock). Each such adjustment shall be
made successively whenever any such New Securities are issued. In determining
whether any New Derivative Securities entitle the holders to subscribe for or
purchase shares of Common Stock at less than $5.00 per share, there shall be
taken into account any consideration received by the Company for such New
Derivative Securities, the value of such consideration, if other than cash, to
be determined in good faith by the Board of Directors of the Company (the "Board
of Directors"), whose determination shall be conclusive and described in a
certificate filed with the records of corporate proceedings of the Company.
Notwithstanding the foregoing, in no event shall an adjustment be made under
this subsection (ii) if such adjustment would result in raising the
then-effective Exercise Price.

               (iii) No adjustment in the Exercise Price shall be required
unless the adjustment would require an increase or decrease of at least 1% in
the Exercise Price then in effect; provided, however, that any adjustments that
by reason of this Section 6(a) are not required to be made shall be carried
forward and taken into account in any subsequent adjustment. All calculations
under this Section 6(a) shall be made to the nearest cent or nearest 1/100th of
a share.

               (iv) Notwithstanding anything to the contrary set forth in this
Section 6(a), no adjustment shall be made to the Exercise Price upon any Exempt
Issuance. "Exempt Issuance" means the issuance of: (A) shares of capital stock
of the Company issued or issuable upon conversion or exercise of any currently
outstanding securities (but not any amendment or modification to such currently
outstanding securities after the date hereof) or any New Securities issued in
accordance with the Purchase Agreement (including the Conversion Shares, the
Warrant Shares, the PIK Dividend Shares and the Redemption Shares, as such terms
are defined in Section 6(j)); (B) shares of capital stock

                                       6

<PAGE>

issued and issuable as payment for outstanding interest under the Company's
outstanding 7% convertible debentures and 4% convertible debentures; (C) shares
or options or warrants for Common Stock granted to officers, directors and
employees of, and consultants to, the Company or its subsidiaries pursuant to
stock option or purchase plans or other compensatory agreements approved by the
Board of Directors, or pursuant to the Syntax Groups Company 2005 Stock
Incentive Plan; (D) shares of Common Stock or preferred stock issued in
connection with any pro rata stock split, stock dividend (including PIK Dividend
Shares) or recapitalization by the Company; (E) shares of capital stock, or
options or warrants to purchase capital stock, issued to a strategic investor in
connection with a strategic commercial agreement as determined by the Board of
Directors; (F) shares of capital stock, or options or warrants to purchase
capital stock, issued to an investor in connection with a joint venture
arrangement where the Company is a participant; (G) shares of capital stock, or
options or warrants to purchase capital stock, issued pursuant to the
acquisition of another corporation or entity by the Company by consolidation,
merger, purchase of all or substantially all of the assets, or other
reorganization in which the Company acquires, in a single transaction or series
of related transactions, all or substantially all of the assets of such other
corporation or entity or fifty percent (50%) or more of the voting power of such
other corporation or entity or fifty percent (50%) or more of the equity
ownership of such other corporation or entity; (H) shares of capital stock
issued in an underwritten public securities offering pursuant to a registration
statement filed under the Securities Act; (I) shares of capital stock, or
options or warrants to purchase capital stock, issued to current or prospective
customers or suppliers of the Company approved by the Board of Directors as
compensation or accommodation in lieu of other payment, compensation or
accommodation to such customer or supplier; (J) shares of capital stock, or
warrants to purchase capital stock, issued to any person that provides services
to the Company as compensation therefor pursuant to an agreement approved by the
Board of Directors; (K) shares of capital stock, or options or warrants to
purchase capital stock, offered in a transaction where the purchase of such
securities by the Holder would cause such transaction to fail to comply with
applicable federal or state securities laws or would cause an applicable
registration or qualification exemption to fail to be available to the Company;
and (L) securities issuable upon conversion or exercise of the securities set
forth in clauses (A) - (K) above.

               (v) The Company from time to time may reduce the Exercise Price
by any amount for any period of time in the discretion of the Board of
Directors.

               (vi) In the event that, at any time as a result of an adjustment
made pursuant to Sections 6(a)(i) through 6(a)(iv) above, the Holder of any
Warrant thereafter surrendered for exercise shall become entitled to receive any
shares of the Company other than shares of the Common Stock, thereafter the
number of such other shares so receivable upon exercise of any such Warrant
shall be subject to adjustment from time to time in a manner and on terms as
nearly equivalent as practicable to the provisions with respect to the Common
Stock contained in Sections 6(a)(i) through 6(a)(v) above, and the other
provisions of this Section 6(a) with respect to the Common Stock shall apply on
like terms to any such other shares.

            (b) In case of any reclassification of the Common Stock (other than
in a transaction to which Section 6(a)(i) applies), any consolidation of the
Company with, or merger of the Company into, any other entity, any merger of
another entity into the Company (other than a merger that does not result in any
reclassification, conversion, exchange or cancellation

                                       7

<PAGE>

of outstanding shares of Common Stock of the Company), any sale or transfer of
all or substantially all of the assets of the Company or any compulsory share
exchange, pursuant to which share exchange the Common Stock is converted into
other securities, cash or other property, then lawful provision shall be made as
part of the terms of such transaction whereby the Holder of this Warrant shall
have the right thereafter, during the Exercise Period, to exercise this Warrant
and obtain only the kind and amount of securities, cash and other property
receivable upon the reclassification, consolidation, merger, sale, transfer or
share exchange by a holder of the number of shares of Common Stock of the
Company into which this Warrant might have been exercisable immediately prior to
the reclassification, consolidation, merger, sale, transfer or share exchange
assuming that such holder of Common Stock failed to exercise rights of election,
if any, as to the kind or amount of securities, cash or other property
receivable upon consummation of such transaction, subject to adjustment as
provided in Section 6(a) above following the date of consummation of such
transaction. As a condition to any such transaction, the Company or the person
formed by the consolidation or resulting from the merger or which acquires such
assets or which acquires the Company's shares, as the case may be, shall make
provisions in its articles or certificate of incorporation or other constituent
document to establish such right. The certificate or articles of incorporation
or other constituent document shall provide for adjustments which, for events
subsequent to the effective date of the certificate or articles of incorporation
or other constituent document, shall be as nearly equivalent as may be
practicable to the adjustments provided for in this Section 6. The provisions of
this Section 6(b) shall similarly apply to successive reclassifications,
consolidations, mergers, sales, transfers or share exchanges.

            (c) If:

                  (i)   the Company shall take any action which would require an
                        adjustment in the Exercise Price pursuant to Section
                        6(a); or

                  (ii)  the Company shall authorize the granting to the holders
                        of its Common Stock generally of rights, warrants or
                        options to subscribe for or purchase any shares of any
                        class or any other rights, warrants or options; or

                  (iii) there shall be any reclassification or change of the
                        Common Stock (other than a subdivision or combination of
                        its outstanding Common Stock or a change in par value)
                        or any consolidation, merger or statutory share exchange
                        to which the Company is a party and for which approval
                        of any stockholders of the Company is required, or the
                        sale or transfer of all or substantially all of the
                        assets of the Company; or

                  (iv)  there shall be a voluntary or involuntary dissolution,
                        liquidation or winding up of the Company;

then, in each such case, the Company shall cause to be mailed to each Holder at
such Holder's address as shown on the books of the transfer agent for the
Warrants, as promptly as possible, but at least 20 calendar days prior to the
applicable date hereinafter specified, a notice stating

                                       8

<PAGE>

(A) the date on which a record is to be taken for the purpose of such dividend,
distribution or granting of rights, warrants or options, or, if a record is not
to be taken, the date as of which the holders of Common Stock of record to be
entitled to such dividend, distribution or rights, warrants or options are to be
determined, or (B) the date on which such reclassification, change,
consolidation, merger, statutory share exchange, sale, transfer, dissolution,
liquidation or winding-up is expected to become effective or occur, and the date
as of which it is expected that holders of Common Stock of record shall be
entitled to exchange their shares of Common Stock for securities or other
property deliverable upon such reclassification, change, consolidation, merger,
statutory share exchange, sale, transfer, dissolution, liquidation or winding
up. Failure to give such notice or any defect therein shall not affect the
legality or validity of the proceedings described in this Section 6(c).

            (d) Whenever the Exercise Price is adjusted as herein provided, the
Company shall promptly cause a notice of the adjusted Exercise Price to be
mailed to each Holder.

            (e) In any case in which Section 6(a) provides that an adjustment
shall become effective immediately after a record date for an event and the date
fixed for such adjustment pursuant to Section 6(a) occurs after such record date
but before the occurrence of such event, the Company may defer until the actual
occurrence of such event issuing to the Holder of any Warrants exercised after
such record date and before the occurrence of such event the additional shares
of Common Stock issuable upon such conversion by reason of the adjustment
required by such event over and above the Common Stock issuable upon such
exercise before giving effect to such adjustment.

            (f) In case the Company shall take any action affecting the Common
Stock, other than actions described in this Section 6, which in the opinion of
the Board of Directors would materially adversely affect the exercise right of
the Holders, the Exercise Price may be adjusted, to the extent permitted by law,
in such manner, if any, and at such time, as the Board of Directors may
determine to be equitable in the circumstances; provided, however, that in no
event shall (i) the Board of Directors be required to take any such action and
(ii) any such action result in an increase in the Exercise Price.

            (g) For the purpose of any computation under Section 2(b) or this
Section 6, the "Current Market Price" per share of Common Stock on any date
means the volume weighted average price of the Common Stock on the ten (10)
consecutive trading days immediately preceding (but not including) such date as
reported for consolidated transactions with respect to securities listed on the
principal national securities exchange on which the Common Stock is listed or
admitted to trading or, if the Common Stock is not listed or admitted to trading
on any national securities exchange, the volume weighted average price of the
Common Stock on the ten (10) consecutive trading days immediately preceding (but
not including) such date in the over-the-counter market, as reported by the
National Association of Securities Dealers, Inc. Automated Quotations System or
such other system then in use or, if the Common Stock is not quoted by any such
organization, the volume weighted average price of the Common Stock as of the
ten (10) consecutive trading days immediately preceding (but not including) such
date determined by an Independent Financial Expert. An "Independent Financial
Expert" shall mean a reputable accounting, appraisal or investment banking firm
that

                                       9

<PAGE>

is, in the reasonable judgment of the Board of Directors, qualified to perform
the task for which such firm has been engaged hereunder, is nationally
recognized and disinterested and Independent with respect to the Company and its
affiliates and is reasonably acceptable to holders owning a majority of all of
the outstanding Warrants issued pursuant to the Purchase Agreement.
"Independent" shall mean any person or entity that (i) is in fact independent,
(ii) does not have any direct financial interest or any material indirect
financial interest in the Company or any of its subsidiaries, or in any
affiliate of the Company or any of its subsidiaries (other than as a result of
holding securities of the Company in trading accounts), and (iii) is not an
officer, employee, promoter, trustee, partner, director or person performing
similar functions for the Company or any of its subsidiaries or any affiliate of
the Company or any of its subsidiaries.

            (h) Upon each adjustment of the Exercise Price (other than an
adjustment under Section 6(a)(iii)), this Warrant shall thereafter evidence the
right to purchase, at the adjusted Exercise Price, that number of shares
(calculated to the nearest thousandth) obtained by dividing (i) the product
obtained by multiplying the number of shares purchasable upon exercise of this
Warrant prior to adjustment of the number of shares by the Exercise Price in
effect prior to adjustment of the Exercise Price, by (ii) the Exercise Price in
effect after such adjustment of the Exercise Price.

            (i) The Company shall not be required to issue fractions of shares
of Common Stock or other capital stock of the Company upon the exercise of this
Warrant, but in lieu thereof, the Company shall round the number of shares to be
issued to the nearest whole number.

            (j) Notwithstanding anything herein to the contrary, the Company
shall not issue any Warrant Shares which, when aggregated with all shares of
Common Stock (the "Conversion Shares") issuable upon conversion of the Company's
6% Redeemable Convertible Preferred Stock (the "Preferred Stock"), any shares of
Common Stock issued upon payment of dividends on the Preferred Stock (the "PIK
Dividend Shares"), and any shares of Common Stock issued upon redemption of the
Preferred Stock (the "Redemption Shares") issued prior to such date of issuance,
would exceed 19.999% of the number of shares of Common Stock outstanding on the
business day immediately preceding the date hereof (such number of shares, the
"Issuable Maximum"). If, on the date of exercise of this Warrant as set forth
herein, (i) the Exercise Price in effect is such that the shares issuable upon
exercise of this Warrant, and any Conversion Shares, PIK Dividend Shares, and
Redemption Shares, together with the aggregate number of shares of Common Stock
that would then be issuable upon conversion, exercise or issuance in full of all
then outstanding Conversion Shares, PIK Dividend Shares, Redemption Shares, or
Warrant Shares would exceed the Issuable Maximum, and (ii) the Company's
stockholders shall not have previously approved the issuance of 20% or more of
the Company's capital stock in connection with the transactions contemplated by
the Purchase Agreement (the "Stockholder Approval"), then the Company shall
issue to the Holder requesting exercise of this Warrant a number of shares of
Common Stock equal to the Holder's pro-rata portion of the Issuable Maximum and,
with respect to the remainder of this Warrant then held by the Holder for which
exercise would result in an issuance of shares of Common Stock in excess of the
Holder's pro-rata portion of the Issuable Maximum (the "Excess Shares"), the
Company shall be prohibited from issuing such Excess Shares, and shall notify
the Holder of the reason

                                      10

<PAGE>

therefor. This Warrant would be unexercisable to such extent until and unless
Stockholder Approval is subsequently obtained, but shall otherwise remain in
full force and effect.

            7. Transfer Taxes. The issuance of any shares or other securities
upon the exercise of this Warrant, and the delivery of certificates or other
instruments representing such shares or other securities, shall be made without
charge to the Holder for any tax or other charge in respect of such issuance.
The Company shall not, however, be required to pay any tax which may be payable
in respect of any transfer involved in the issue and delivery of any certificate
in a name other than that of the Holder and the Company shall not be required to
issue or deliver any such certificate unless and until the person or persons
requesting the issue thereof shall have paid to the Company the amount of such
tax or shall have established to the satisfaction of the Company that such tax
has been paid.

            8. Loss or Mutilation of Warrant. Upon receipt of evidence
reasonably satisfactory to the Company of the loss, theft, destruction, or
mutilation of any Warrant (and upon surrender of any Warrant if mutilated), and
upon reimbursement of the Company's reasonable incidental expenses, the Company
shall execute and deliver to the Holder thereof a new Warrant of like date,
tenor, and denomination.

            9. No Rights as a Stockholder. The Holder of any Warrant shall not
have, solely on account of such status, any rights of a stockholder of the
Company, either at law or in equity, or to any notice of meetings of
stockholders or of any other proceedings of the Company, except as provided in
this Warrant.

            10. Governing Law. This Warrant shall be construed in accordance
with the laws of the State of Texas applicable to contracts made and performed
within such State, without regard to principles of conflicts of law.

                                      * * *

Dated:   December __, 2005

                                                    SYNTAX-BRILLIAN CORPORATION

                                                     By:________________________
                                                         Wayne A. Pratt,
                                                         Chief Financial Officer

                                       11
<PAGE>

                               FORM OF ASSIGNMENT

(To be executed by the registered holder if such holder desires to transfer the
attached Warrant.)

            FOR VALUE RECEIVED, ___________________ hereby sells, assigns, and
transfers unto ________________ a Warrant to purchase __________ shares of
Common Stock, par value $0.001 per share, of Syntax-Brillian Corporation (the
"Company"), together with all right, title, and interest therein, and does
hereby irrevocably constitute and appoint ____________________ attorney to
transfer such Warrant on the books of the Company, with full power of
substitution.

                                             Dated:_____________________

                                             By:______________________________
                                                           Signature

      The signature on the foregoing Assignment must correspond to the name as
written upon the face of this Warrant in every particular, without alteration or
enlargement or any change whatsoever.

<PAGE>

To:    Syntax-Brillian Corporation
       1600 North Desert Drive
       Tempe, Arizona 85281-1230
       Attention:  Chief Executive Officer

                               NOTICE OF EXERCISE

      The undersigned hereby exercises his or its rights to purchase _______
Warrant Shares covered by the within Warrant and tenders payment herewith in the
amount of $_________ by [tendering cash or delivering a certified check or bank
cashier's check, payable to the order of the Company] [surrendering ______
shares of Common Stock received upon exercise of the attached Warrant, which
shares have a Current Market Price equal to such payment] in accordance with the
terms thereof.

                     _____________________________________
                     _____________________________________
                     _____________________________________
                    (Print Name, Address and Social Security
                          or Tax Identification Number)

Holder requests delivery to be made: (check one)

[ ]   By delivery of physical certificates in the name above and delivered to
      the above address

[ ]   Through Depository Trust Corporation, if eligible
      (Account )_____________________________________)

and, if such number of Warrant Shares shall not be all the Warrant Shares
covered by the within Warrant, that a new Warrant for the balance of the Warrant
Shares covered by the within Warrant be registered in the name of, and delivered
to, the undersigned at the address stated below.

                                                Dated:__________________________

                                                By:_____________________________
                                                           Print Name

                                                ________________________________
                                                           Signature

Address:
_____________________________________
_____________________________________
_____________________________________<PAGE>

                                                                    EXHIBIT 4.14

                          REGISTRATION RIGHTS AGREEMENT

         This Registration Rights Agreement (this "Agreement") is made and
entered into as of December 29, 2005, by and among Syntax-Brillian Corporation,
a Delaware corporation (the "Company"), and the persons and entities listed on
Exhibit A hereto (each, a "Purchaser" and, collectively, the "Purchasers").

         WHEREAS, upon the terms and subject to the conditions of the Securities
Purchase Agreement, dated as of December 28, 2005 (the "Purchase Agreement"),
the Company has agreed to issue and sell to the Purchasers the Company's 6%
Redeemable Convertible Preferred Stock, par value $0.001 per share (the
"Preferred Stock"), and Warrants to purchase shares of its Common Stock; and

         WHEREAS, to induce the Purchasers to execute and deliver the Purchase
Agreement and to purchase the Preferred Stock and the Warrants, the Company has
agreed to provide certain registration rights under the Securities Act of 1933,
as amended, with respect to the Conversion Shares, the Warrant Shares, the PIK
Dividend Shares and the Redemption Shares.

         NOW, THEREFORE, in consideration of the representations, warranties and
agreements contained herein and other good and valuable consideration, the
receipt and legal adequacy of which are hereby acknowledged by the parties, the
Company and the Purchasers hereby agree as follows:

      1. Definitions.

         Capitalized terms used but not otherwise defined herein shall have the
meanings given such terms in the Purchase Agreement. As used in this Agreement,
the following terms shall have the following meanings:

         "Affiliate" means, with respect to any Person, any other Person that
directly or indirectly controls or is controlled by or under common control with
such Person. For the purposes of this definition, "control," when used with
respect to any Person, means the possession, direct or indirect, of the power to
direct or cause the direction of the management and policies of such Person,
whether through the ownership of voting securities, by contract or otherwise;
and the terms "affiliated," "controlling" and "controlled" have meanings
correlative to the foregoing.

         "Blackout Period" shall have the meaning set forth in Section 3(1).

         "Board" shall have the meaning set forth in Section 3(1).

         "Business Day" means any day except Saturday, Sunday and any day which
is a legal holiday or a day on which banking institutions in the State of
Arizona generally are authorized or required by law or other government actions
to close.

<PAGE>

         "Commission" means the Securities and Exchange Commission.

         "Common Stock" means the Company's Common Stock, $0.001 par value.

         "Conversion Shares" shall have the meaning set forth in the definition
of "Registrable Securities."

         "Effectiveness Date" means with respect to the Registration Statement
the earlier of (i) the 90th day following the Closing Date (or the 120th day
following the Closing Date in the event that the Registration Statement is
reviewed by the Commission), before which the Company will cause the
Registration Statement to become effective, and (ii) the 5th Business Day after
the date on which the Commission informs the Company (a) that the Commission
will not review the Registration Statement, or (b) that the Company may request
the acceleration of the effectiveness of the Registration Statement.

         "Effectiveness Period" shall have the meaning set forth in Section 2.

         "Event" shall have the meaning set forth in Section 8(d).

         "Exchange Act" means the Securities Exchange Act of 1934, as amended.

         "Holder" means, collectively, each holder from time to time of
Registrable Securities including, without limitation, each Purchaser and its
assignees. To the extent this Agreement refers to an election, consent, waiver,
request or approval of or by the Holder, such reference shall mean an election,
consent, waiver, request or approval by the holders of a majority in interest of
the then-outstanding Registrable Securities (on an as exercised basis).

         "Indemnified Party" shall have the meaning set forth in Section 6(c).

         "Indemnifying Party" shall have the meaning set forth in Section 6(c).

         "Liquidated Damages" shall have the meaning set forth in Section 8(d).

         "Losses" shall have the meaning set forth in Section 6(a).

         "Person" means an individual or a corporation, partnership, trust,
incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or political subdivision
thereof) or other entity of any kind.

         "PIK Dividend Shares" shall have the meaning set forth in the
definition of "Registrable Securities."

         "Proceeding" means an action, claim, suit, investigation or proceeding
(including, without limitation, an investigation or partial proceeding, such as
a deposition), whether commenced or threatened.

         "Prospectus" means the prospectus included in the Registration
Statement (including, without limitation, a prospectus that includes any
information previously omitted from a prospectus filed as part of an effective
registration statement in reliance upon Rule 430A promulgated under the
Securities Act), as amended or supplemented by any prospectus supplement, with
respect to the terms of the offering of any portion of the Registrable
Securities

                                      -2-

<PAGE>

covered by the Registration Statement, and all other amendments and supplements
to the Prospectus, including post-effective amendments, and all material
incorporated by reference in such Prospectus.

         "Redemption Shares" shall have the meaning set forth in the definition
of "Registrable Securities."

         "Registrable Securities" means (a) all shares of Common Stock issuable
upon conversion of the Preferred Stock (collectively, the "Conversion Shares");
(b) all shares of Common Stock issuable upon exercise of the Warrants
(collectively, the "Warrant Shares"); (c) all shares of Common Stock issuable in
payment of dividends on the Preferred Stock (collectively, the "PIK Dividend
Shares"); (d) all shares of Common Stock issuable upon redemption of the
Preferred Stock (collectively, the "Redemption Shares"); and (e) any securities
issued or issuable upon any stock split, stock dividend, recapitalization or
similar event with respect to the foregoing and any other securities issued in
exchange of or replacement of the foregoing; until, in each such case (i) a
Registration Statement covering the Conversion Shares, the Warrant Shares, the
PIK Dividend Shares and the Redemption Shares has been declared effective by the
Commission and continues to be effective during the Effectiveness Period, or
(ii) such Conversion Shares, Warrant Shares, PIK Dividend Shares, or Redemption
Shares are sold in compliance with Rule 144 or may be sold pursuant to Rule
144(k), after which time such shares shall not be Registrable Securities.

         "Registration Statement" means the registration statement, including
the Prospectus, amendments and supplements to such registration statement or
Prospectus, including pre- and post-effective amendments, all exhibits thereto,
and all material incorporated by reference in such registration statement, for
the resale of the Registrable Securities required to be filed by the Company
with the Commission pursuant to this Agreement.

         "Required Filing Date" means the forty-fifth (45th) day immediately
following the Closing Date.

         "Rule 144" means Rule 144 promulgated by the Commission pursuant to the
Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the Commission having substantially the
same effect as such Rule.

         "Rule 158" means Rule 158 promulgated by the Commission pursuant to the
Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the Commission having substantially the
same effect as such Rule.

         "Rule 415" means Rule 415 promulgated by the Commission pursuant to the
Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the Commission having substantially the
same effect as such Rule.

         "Securities Act" means the Securities Act of 1933, as amended.

         "Special Counsel" means any one firm of special counsel to Holder, for
which Holder will be reimbursed by the Company pursuant to the Purchase
Agreement.

         "Warrant Shares" shall have the meaning set forth in the definition of
"Registrable Securities."

                                      -3-

<PAGE>

      2. Registration. On or prior to the Required Filing Date, the Company
shall prepare and file with the Commission a Registration Statement covering the
resale of the Registrable Securities for an offering to be made on a continuous
basis pursuant to Rule 415. The Registration Statement shall be on Form S-3
(except if the Company is not then eligible to register for resale the
Registrable Securities on Form S-3, in which case such registration shall be on
another appropriate form in accordance with the Securities Act and the rules
promulgated thereunder) and shall contain (except if otherwise directed by the
Purchasers) the "Plan of Distribution" substantially in the form attached hereto
as Exhibit B. The Company shall (i) not permit any securities other than the
Registrable Securities to be included in the Registration Statement (except for
securities which are subject to written registration rights agreements entered
into by the Company prior to December 15, 2005), (ii) cause the Registration
Statement to be declared effective under the Securities Act (including filing
with the Commission a request for acceleration of effectiveness in accordance
with Rule 461 promulgated under the Securities Act within five (5) Business Days
after the date that the Company is notified (orally or in writing, whichever is
earlier) by the Commission that the Registration Statement will not be
"reviewed," or not be subject to further review) as soon as possible after the
filing thereof, but in any event prior to the Effectiveness Date, and (iii) keep
such Registration Statement continuously effective under the Securities Act for
a period of two years from the Closing Date (the "Effectiveness Period").

      3. Registration Procedures; Company's Obligations.

         In connection with the registration of the Registrable Securities, the
Company shall:

         (a) Prepare and file with the Commission on or prior to the Required
Filing Date, a Registration Statement on Form S-3 (or if the Company is not then
eligible to register for resale the Registrable Securities on Form S-3, then
such registration shall be on another appropriate form in accordance with the
Securities Act and the Rules promulgated thereunder), and cause the Registration
Statement to become effective and remain effective as provided herein; provided,
however, that not less than three (3) Business Days prior to the filing of the
Registration Statement or any related Prospectus or any amendment or supplement
thereto (including any document that would be incorporated therein by
reference), the Company shall (i) furnish to the Holder and any Special Counsel,
copies of all such documents proposed to be filed, which documents (other than
those incorporated by reference) will be subject to the timely review of and
comment by such Special Counsel, and (ii) at the request of the Holder cause its
officers and directors, counsel and independent certified public accountants to
respond to such inquiries as shall be necessary, in the reasonable opinion of
such Special Counsel, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file the Registration Statement or
any such Prospectus or any amendments or supplements thereto to which the Holder
or any Special Counsel shall reasonably object in writing within three (3)
Business Days of their receipt thereof.

         (b) (i) Prepare and file with the Commission such amendments, including
post-effective amendments, to the Registration Statement as may be necessary to
keep the Registration Statement continuously effective as to the applicable
Registrable Securities for the Effectiveness Period in order to register for
resale under the Securities Act all of the Registrable Securities; (ii) cause
the related Prospectus to be amended or supplemented by any required Prospectus
supplement, and as so supplemented or amended to be filed pursuant to Rule 424
(or

                                      -4-

<PAGE>

any similar provisions then in force) promulgated under the Securities Act;
(iii) respond promptly to any comments received from the Commission with respect
to the Registration Statement or any amendment thereto and promptly provide to
the Holder upon request of the Holder true and complete copies of all
correspondence from and to the Commission relating to the Registration
Statement; and (iv) comply in all material respects with the provisions of the
Securities Act and the Exchange Act with respect to the disposition of all
Registrable Securities covered by the Registration Statement during the
applicable period in accordance with the intended methods of disposition by the
Holder set forth in the Registration Statement as so amended or in such
Prospectus as so supplemented.

         (c) Notify the Holder of Registrable Securities to be sold and any
Special Counsel promptly (and, in the case of (i)(A) below, not less than three
(3) Business Days prior to such filing and, in the case of (i)(C) below, no
later than the first Business Day following the date on which the Registration
Statement becomes effective) and (if requested by any such Person) confirm such
notice in writing no later than three (3) Business Days following the day (i)(A)
when a Prospectus or any Prospectus supplement or post-effective amendment to
the Registration Statement is proposed to be filed, (B) when the Commission
notifies the Company whether there will be a "review" of such Registration
Statement and whenever the Commission comments in writing on such Registration
Statement, and (C) with respect to the Registration Statement or any
post-effective amendment, when the same has become effective; (ii) of any
request by the Commission or any other Federal or state governmental authority
for amendments or supplements to the Registration Statement or Prospectus or for
additional information; (iii) of the issuance by the Commission of any stop
order suspending the effectiveness of the Registration Statement covering any or
all of the Registrable Securities or the initiation of any Proceedings for that
purpose; (iv) of the receipt by the Company of any notification with respect to
the suspension of the qualification or exemption from qualification of any of
the Registrable Securities for sale in any jurisdiction, or the initiation or
threatening of any Proceeding for such purpose; and (v) of the occurrence of any
event that makes any statement made in the Registration Statement or Prospectus
or any document incorporated or deemed to be incorporated therein by reference
untrue in any material respect or that requires any revisions to the
Registration Statement, Prospectus or other documents so that, in the case of
the Registration Statement or the Prospectus, as the case may be, it will not
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading.

         The Company shall promptly furnish to the Special Counsel upon its
request, without charge, (i) any correspondence from the Commission or the
Commission's staff to the Company or its representatives relating to any
Registration Statement, and (ii) promptly after the same is prepared and filed
with the Commission, a copy of any written response to the correspondence
received from the Commission.

         (d) Use its best efforts to avoid the issuance of, or, if issued,
obtain the withdrawal of, (i) any order suspending the effectiveness of the
Registration Statement, or (ii) any suspension of the qualification (or
exemption from qualification) of any of the Registrable Securities for sale in
any U.S. jurisdiction, at the earliest practicable moment.

         (e) Furnish to the Holder and any Special Counsel upon request, without
charge, at least one conformed copy of each Registration Statement and each
amendment thereto,

                                      -5-

<PAGE>

including financial statements and schedules, all documents incorporated or
deemed to be incorporated therein by reference, and all exhibits to the extent
requested by such Person (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission.

         (f) Promptly deliver to the Holder and any Special Counsel upon
request, without charge, as many copies of the Registration Statement,
Prospectus or Prospectuses (including each form of prospectus) and each
amendment or supplement thereto as such Persons may reasonably request; and the
Company hereby consents to the use of such Prospectus and each amendment or
supplement thereto by the selling Holder in connection with the offering and
sale of the Registrable Securities covered by such Prospectus and any amendment
or supplement thereto. Should the Holder offer or sell the Registrable
Securities, such Holder agrees to comply with all applicable securities laws.

         (g) Prior to any public offering of Registrable Securities, use its
best efforts to register or qualify or cooperate with the selling Holder and any
Special Counsel in connection with the registration or qualification (or
exemption from such registration or qualification) of such Registrable
Securities for offer and sale under the securities or Blue Sky laws of such
jurisdictions within the United States as the Holder reasonably requests in
writing, to keep each such registration or qualification (or exemption
therefrom) effective during the Effectiveness Period and to do any and all other
acts or things necessary or advisable to enable the disposition in such
jurisdictions of the Registrable Securities covered by a Registration Statement;
provided, however, that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified or to take
any action that would subject it to general service of process in any such
jurisdiction where it is not then so subject or subject the Company to any tax
in any such jurisdiction where it is not then so subject.

         (h) Cooperate with the Holder to facilitate the timely preparation and
delivery of certificates representing Registrable Securities to be sold pursuant
to a Registration Statement and to enable such Registrable Securities to be in
such denominations and registered in such names as the Holder may request at
least two (2) Business Days prior to any sale of Registrable Securities.

         (i) Upon the occurrence of any event contemplated by Section 3(c)(v),
promptly prepare a supplement or amendment, including a post-effective
amendment, to the Registration Statement or a supplement to the related
Prospectus or any document incorporated or deemed to be incorporated therein by
reference, and file any other required document so that, as thereafter
delivered, neither the Registration Statement nor such Prospectus will contain
an untrue statement of a material fact or omit to state a material fact required
to be stated therein or necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading.

         (j) Use its best efforts to cause all Registrable Securities relating
to such Registration Statement to be listed on any securities exchange,
quotation system, market or over-the-counter bulletin board, if any, on which
the same securities issued by the Company are then listed as and when required
pursuant to the Purchase Agreement.

         (k) Comply in all material respects with all applicable rules and
regulations of the Commission and make generally available to its security
holders earning statements satisfying the provisions of Section 11(a) of the
Securities Act and Rule 158 not later than forty-

                                      -6-

<PAGE>

five (45) days after the end of any twelve (12) month period (or ninety (90)
days after the end of any twelve (12) month period if such period is a fiscal
year) commencing on the first day of the first fiscal quarter of the Company
after the effective date of the Registration Statement, which statement shall
conform to the requirements of Rule 158.

         (l) If (i) there is material non-public information regarding the
Company which the Company's Board of Directors (the "Board") reasonably
determines not to be in the Company's best interest to disclose and which the
Company is not otherwise required to disclose, or (ii) there is a significant
business opportunity (including, but not limited to, the acquisition or
disposition of assets (other than in the ordinary course of business) or any
merger, consolidation, tender offer or other similar transaction) available to
the Company which the Board reasonably determines not to be in the Company's
best interest to disclose and which the Company would be required to disclose
under the Registration Statement, then the Company may suspend effectiveness of
a Registration Statement and suspend the sale of Registrable Securities under a
Registration Statement one (1) time every three (3) months or three (3) times in
any twelve month period, provided that the Company may not suspend its
obligation for more than thirty (30) days in the aggregate in any twelve month
period if suspension is for any of the reasons listed above or sixty (60) days
in the aggregate in any twelve month period for any other reason (each, a
"Blackout Period"); provided, however, that no such suspension shall be
permitted for more than twenty (20) consecutive days, arising out of the same
set of facts, circumstances or transactions.

         (m) Within two (2) Business Days after the Registration Statement which
includes the Registrable Securities is ordered effective by the Commission, the
Company shall deliver, and shall cause legal counsel for the Company to deliver,
to the transfer agent for such Registrable Securities (with copies to the Holder
whose Registrable Securities are included in such Registration Statement)
confirmation that the Registration Statement has been declared effective by the
Commission in the form attached hereto as Exhibit C.

      4. Registration Procedures; Holder's Obligations

         In connection with the registration of the Registrable Securities, the
Holder shall:

         (a) Furnish to the Company a completed Questionnaire in the form
attached as Exhibit D not less than five Business Days prior to the Required
Filing Date or by the end of the three Business Days following the date on which
the Holder receives draft materials in accordance with Section 3(a).

         (b) If the Registration Statement refers to the Holder by name or
otherwise as the holder of any securities of the Company, have the right to
require (if such reference to the Holder by name or otherwise is not required by
the Securities Act or any similar federal statute then in force) the deletion of
the reference to the Holder in any amendment or supplement to the Registration
Statement that will be filed or prepared subsequent to the time that such
reference ceases to be required.

         (c) (i) not sell any Registrable Securities under the Registration
Statement until it has received copies of the Prospectus as then amended or
supplemented as contemplated in Section 3(f) and notice from the Company that
such Registration Statement and any post-effective amendments thereto have
become effective as contemplated by Section 3(c), (ii) comply with the
prospectus delivery requirements of the Securities Act as applicable to it in

                                      -7-

<PAGE>

connection with sales of Registrable Securities pursuant to the Registration
Statement, and (iii) furnish to the Company information regarding such Holder
and the distribution of such Registrable Securities as is required by law to be
disclosed in the Registration Statement, and the Company may exclude from such
registration the Registrable Securities of the Holder if it fails to furnish
such information within a reasonable time prior to the filing of each
Registration Statement, supplemented Prospectus and/or amended Registration
Statement.

         (d) upon receipt of a notice from the Company of the occurrence of any
event of the kind described in Section 3(c)(ii), 3(c)(iii), 3(c)(iv), 3(c)(v) or
3(m), forthwith discontinue disposition of such Registrable Securities under the
Registration Statement until the Holder's receipt of the copies of the
supplemented Prospectus and/or amended Registration Statement contemplated by
Section 3(i), or until it is advised in writing by the Company that the use of
the applicable Prospectus may be resumed, and, in either case, has received
copies of any additional or supplemental filings that are incorporated or deemed
to be incorporated by reference in such Prospectus or Registration Statement.

         Each Holder hereby (i) acknowledges to the Company that the Commission
currently takes the position that coverage of short sales of shares of Common
Stock "against the box" made prior to the Effectiveness Date with any security
covered by any Prospectus is a violation of Section 5 of the Securities Act, as
set forth in Item 65, Section 5 under Section A, of the Manual of Publicly
Available Telephone Interpretations, dated June 1997, compiled by the Office of
Chief Counsel, Division of Corporation Finance, (ii) agrees (on behalf of itself
or any Person over which it has direct control) not to use any of the securities
covered by any Prospectus to cover any short sales, hedging or similar
transactions with the same economic effect as a short sale, made prior to the
Effectiveness Date, and (iii) agrees to comply with Regulation M under the
federal securities laws.

      5. Registration Expenses

         All reasonable fees and expenses incident to the performance of or
compliance with this Agreement by the Company shall be borne by the Company
whether or not the Registration Statement is filed or becomes effective and
whether or not any Registrable Securities are sold pursuant to the Registration
Statement. The fees and expenses referred to in the foregoing sentence shall
include, without limitation, the following: (i) all registration and filing fees
(including, without limitation, fees and expenses (A) with respect to filings
required to be made with each securities exchange or other market on which
Registrable Securities are required hereunder to be listed, (B) with respect to
filings required to be made with the Commission or with the NASD pursuant to
NASD Conduct Rule 2710, if required, and (C) in compliance with state securities
or Blue Sky laws); (ii) printing expenses (including, without limitation,
expenses of printing certificates for Registrable Securities and of printing
prospectuses if the printing of prospectuses is requested by the holders of a
majority of the Registrable Securities included in the Registration Statement);
(iii) messenger, telephone and delivery expenses of the Company; (iv) fees and
disbursements of counsel for the Company; and (v) fees and expenses of all other
Persons retained by the Company in connection with the consummation of the
transactions contemplated by this Agreement, including, without limitation, the
Company's independent public accountants (including the expenses of any comfort
letters or costs associated with the delivery by independent public accountants
of a comfort letter or comfort letters). In addition, the Company shall be
responsible for all of its internal expenses incurred in connection with the
consummation of the transactions contemplated by this

                                      -8-

<PAGE>

Agreement (including, without limitation, all salaries and expenses of its
officers and employees performing legal or accounting duties), the expense of
any annual audit, and the fees and expenses incurred in connection with the
listing of the Registrable Securities on any securities exchange as required
hereunder.

      6. Indemnification

         (a) Indemnification by the Company. The Company shall, notwithstanding
any termination of this Agreement, indemnify and hold harmless each Purchaser,
its permitted assignees, officers, directors, agents, brokers (including brokers
who offer and sell Registrable Securities as principal as a result of a pledge
or any failure to perform under a margin call of Common Stock), investment
advisors and employees, each Person who controls any such Purchaser or permitted
assignee (within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act) and the officers, directors, agents and employees of each
such controlling Person, and the respective successors, assigns, estate and
personal representatives of each of the foregoing, to the fullest extent
permitted by applicable law, from and against any and all claims, losses,
damages, liabilities, penalties, judgments, costs (including, without
limitation, costs of investigation) and expenses (including, without limitation,
reasonable attorneys' fees and expenses) (collectively, "Losses"), as incurred,
arising out of or relating to any untrue or alleged untrue statement of a
material fact contained in the Registration Statement, any Prospectus, as
supplemented or amended, if applicable, or arising out of or relating to any
omission or alleged omission of a material fact required to be stated therein or
necessary to make the statements therein (in the case of any Prospectus or form
of prospectus or supplement thereto, in the light of the circumstances under
which they were made) not misleading, except (i) to the extent, but only to the
extent, that such untrue statements or omissions are based solely upon
information regarding the Holder furnished in writing to the Company by the
Holder expressly for use therein, which information was reviewed and expressly
approved by the Holder or Special Counsel expressly for use in the Registration
Statement, such Prospectus or form of Prospectus or in any amendment or
supplement thereto, or (ii) as a result of the failure of the Holder to deliver
a Prospectus, as amended or supplemented, to a purchaser in connection with an
offer or sale. The Company shall notify the Holder promptly of the institution,
threat or assertion of any Proceeding of which the Company is aware in
connection with the transactions contemplated by this Agreement. Such indemnity
shall remain in full force and effect regardless of any investigation made by or
on behalf of an Indemnified Party (as defined in Section 6(c) hereof) and shall
survive the transfer of the Registrable Securities by the Holder.

         (b) Indemnification by Purchaser. Each Purchaser and its permitted
assignees shall, severally and not jointly, indemnify and hold harmless the
Company, its directors, officers, agents and employees, each Person who controls
the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of
such controlling Persons, and the respective successors, assigns, estate and
personal representatives of each of the foregoing, to the fullest extent
permitted by applicable law, from and against any and all Losses, as incurred,
arising out of or relating to (i) the failure of the Holder to deliver a
Prospectus, as amended or supplemented, to a purchaser in connection with a
purchase or sale, (ii) the Holder's use of a representation or prospectus other
than the Prospectus, as amended or supplemented, in connection with a purchase
or sale, or (iii) any untrue or alleged untrue statement of a material fact
contained in the Registration Statement, any Prospectus, as supplemented or
amended, if applicable, or arising out of or relating to any omission or alleged
omission of a material fact required to be stated therein or necessary to make

                                      -9-

<PAGE>

the statements therein (in the case of any Prospectus or form of Prospectus or
supplement thereto, in the light of the circumstances under which they were
made) not misleading, to the extent, but only to the extent, that (A) such
untrue statement or omission is contained in or omitted from any information so
furnished in writing by the Holder or the Special Counsel to the Company
specifically for inclusion in the Registration Statement or such Prospectus, and
(B) such information was reasonably relied upon by the Company for use in the
Registration Statement, such Prospectus or such form of Prospectus or, to the
extent that such information relates to the Holder or the Holder's proposed
method of distribution of Registrable Securities, was reviewed and expressly
approved in writing by the Holder expressly for use in the Registration
Statement, such Prospectus or such form of Prospectus Supplement.
Notwithstanding anything to the contrary contained herein, the Holder shall be
liable under this Section 6(b) for only that amount as does not exceed the net
proceeds to the Holder as a result of the sale of Registrable Securities
pursuant to such Registration Statement.

         (c) Conduct of Indemnification Proceedings. If any Proceeding shall be
brought or asserted against any Person entitled to indemnity pursuant to Section
6(a) or 6(b) hereunder (an "Indemnified Party"), such Indemnified Party promptly
shall notify the Person from whom indemnity is sought (the "Indemnifying Party)
in writing, and the Indemnifying Party shall assume the defense thereof,
including the employment of counsel reasonably satisfactory to the Indemnified
Party and the payment of all fees and expenses incurred in connection with
defense thereof; provided, that the failure of any Indemnified Party to give
such notice shall not relieve the Indemnifying Party of its obligations or
liabilities pursuant to this Agreement, except (and only) to the extent that it
shall be finally determined by a court of competent jurisdiction (which
determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.

         An Indemnified Party shall have the right to employ separate counsel in
any such Proceeding and to participate in the defense thereof, but the fees and
expenses of such counsel shall be at the expense of such Indemnified Party or
Parties unless: (i) the Indemnifying Party has agreed in writing to pay such
fees and expenses; or (ii) the Indemnifying Party shall have failed promptly to
assume the defense of such Proceeding and to employ counsel reasonably
satisfactory to such Indemnified Party in any such Proceeding; or (iii) the
named parties to any such Proceeding (including any impleaded parties) include
both such Indemnified Party and the Indemnifying Party, and such Indemnified
Party shall have been advised by counsel that a conflict of interest is likely
to exist if the same counsel were to represent such Indemnified Party and the
Indemnifying Party (in which case, if such Indemnified Party notifies the
Indemnifying Party in writing that it elects to employ separate counsel at the
expense of the Indemnifying Party, the Indemnifying Party shall not have the
right to assume the defense thereof and such counsel shall be at the expense of
the Indemnifying Party). The Indemnifying Party shall not be liable for any
settlement of any such Proceeding effected without its written consent, which
consent shall not be unreasonably withheld, conditioned or delayed. No
Indemnifying Party shall, without the prior written consent of the Indemnified
Party, which consent shall not unreasonably be withheld, conditioned or delayed,
effect any settlement of any pending Proceeding in respect of which any
Indemnified Party is a party, unless such settlement includes an unconditional
release of such Indemnified Party from all liability on claims that are the
subject matter of such Proceeding.

         All reasonable fees and expenses of the Indemnified Party (including
reasonable fees and expenses to the extent incurred in connection with
investigating or preparing to defend

                                      -10-

<PAGE>

such Proceeding in a manner not inconsistent with this Section) shall be paid to
the Indemnified Party, as incurred, within ten (10) Business Days of written
notice thereof to the Indemnifying Party (regardless of whether it is ultimately
determined that an Indemnified Party is not entitled to indemnification
hereunder; provided, that the Indemnifying Party may require such Indemnified
Party to undertake to reimburse all such fees and expenses to the extent it is
finally judicially determined that such Indemnified Party is not entitled to
indemnification hereunder or pursuant to applicable law).

         (d) Contribution. If a claim for indemnification under Section 6(a) or
6(b) is unavailable to an Indemnified Party because of a failure or refusal of a
governmental authority to enforce such indemnification in accordance with its
terms (by reason of public policy or otherwise), then each Indemnifying Party,
in lieu of indemnifying such Indemnified Party, shall contribute to the amount
paid or payable by such Indemnified Party as a result of such Losses, in such
proportion as is appropriate to reflect the relative fault of the Indemnifying
Party and Indemnified Party in connection with the actions, statements or
omissions that resulted in such Losses as well as any other relevant equitable
considerations. The relative fault of such Indemnifying Party and Indemnified
Party shall be determined by reference to, among other things, whether any
action in question, including any untrue or alleged untrue statement of a
material fact or omission or alleged omission of a material fact, has been taken
or made by, or relates to information supplied by, such Indemnifying Party or
Indemnified Party, and the parties' relative intent, knowledge, access to
information and opportunity to correct or prevent such action, statement or
omission. The amount paid or payable by a party as a result of any Losses shall
be deemed to include, subject to the limitations set forth in Section 6(c), any
reasonable attorneys' or other reasonable fees or expenses incurred by such
party in connection with any Proceeding to the extent such party would have been
indemnified for such fees or expenses if the indemnification provided for under
Section 6(a) or 6(b) was available to such party in accordance with its terms.
Notwithstanding anything to the contrary contained herein, the Holder shall be
liable or required to contribute under this Section 6(d) for only that amount as
does not exceed the net proceeds to the Holder as a result of the sale of
Registrable Securities pursuant to the Registration Statement.

         The parties hereto agree that it would not be just and equitable if
contribution pursuant to this Section 6(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account
the equitable considerations referred to in the immediately preceding paragraph.
No Person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any Person
who was not guilty of such fraudulent misrepresentation.

         The indemnity and contribution agreements contained in this Section are
in addition to any liability that the Indemnifying Parties may have to the
Indemnified Parties.

      7. Rule 144.

         As long as the Holder owns Registrable Securities, the Company
covenants to timely file (or obtain extensions in respect thereof and file
within the applicable grace period) all reports required to be filed by the
Company after the date hereof pursuant to Section 13(a) or 15(d) of the Exchange
Act. As long as the Holder owns Registrable Securities, if the Company is not
required to file reports pursuant to Section 13(a) or 15(d) of the Exchange Act,
it will prepare and furnish to the Holder and make publicly available in
accordance with Rule 144(c)

                                      -11-

<PAGE>

promulgated under the Securities Act annual and quarterly financial statements,
together with a discussion and analysis of such financial statements in form and
substance substantially similar to those that would otherwise be required to be
included in reports required by Section 13(a) or 15(d) of the Exchange Act, as
well as any other information required thereby, in the time period that such
filings would have been required to have been made under the Exchange Act. The
Company further covenants that it will take such further action as the Holder
may reasonably request, all to the extent required from time to time to enable
the Holder to sell Conversion Shares, Warrant Shares, PIK Dividend Shares and
Redemption Shares without registration under the Securities Act within the
limitation of the exemptions provided by Rule 144 promulgated under the
Securities Act, including providing any legal opinions of counsel to the Company
referred to in the Purchase Agreement. Upon the request of any Holder, the
Company shall deliver to such Holder a written certification of a duly
authorized officer as to whether it has complied with such requirements.

      8. Miscellaneous.

         (a) Remedies. The remedies provided in this Agreement and the Purchase
Agreement are cumulative and not exclusive of any remedies provided by law. In
the event of a breach by the Company or by the Holder of any of their
obligations under this Agreement, the Holder or the Company, as the case may be,
in addition to being entitled to exercise all rights granted by law and under
this Agreement, including recovery of damages, will be entitled to specific
performance of its rights under this Agreement. The Company and the Holder agree
that monetary damages would not provide adequate compensation for any losses
incurred by reason of a breach by it of any of the provisions of this Agreement
and hereby further agrees that, in the event of any action for specific
performance in respect of such breach, it shall waive the defense that a remedy
at law would be adequate.

         (b) No Inconsistent Agreements. Neither the Company nor any of its
Affiliates has as of the date hereof entered into, nor shall the Company or any
of its Affiliates, on or after the date of this Agreement, enter into, any
agreement with respect to its securities that is inconsistent with the rights
granted to the Holder in this Agreement or otherwise conflicts with the
provisions hereof. Without limiting the generality of the foregoing, without the
written consent of the Holder, after the date hereof the Company shall not grant
to any Person the right to request the Company to register any securities of the
Company under the Securities Act if the rights so granted are inconsistent with
the rights granted to the Holder set forth herein, or otherwise prevent the
Company with complying with all of its obligations hereunder.

         (c) No Piggyback on Registrations. Neither the Company nor any of its
security holders (other than the Holder in such capacity pursuant hereto) may
include securities of the Company in the Registration Statement (except for
securities held by other security holders which are subject to written
registration rights agreements entered into by the Company prior to December 15,
2005, which securities may be included in the Registration Statement).

         (d) Failure to File Registration Statement and Other Events. The
Company and the Holder agree that the Holder will suffer damages if the
Registration Statement is not filed on or prior to the Required Filing Date or
is not declared effective by the Commission on or prior to the Effectiveness
Date and maintained in the manner contemplated herein during the Effectiveness
Period or if certain other events occur. The Company and the Holder further
agree that it would not be feasible to ascertain the extent of such damages with
precision. Accordingly,

                                      -12-

<PAGE>

if (i) the Registration Statement is not filed on or prior to the Required
Filing Date, or is not declared effective by the Commission on or prior to the
Effectiveness Date, or (ii) the Company fails to file with the Commission a
request for acceleration in accordance with Rule 461 promulgated under the
Securities Act within five (5) Business Days after the date that the Company is
notified (orally or in writing, whichever is earlier) by the Commission that a
Registration Statement will not be "reviewed," or not subject to further review,
or (iii) the Registration Statement is filed with and declared effective by the
Commission but thereafter (otherwise than as permitted by item (iv) below)
ceases to be effective or available as to all Registrable Securities for 30 days
during the Effectiveness Period, without being succeeded within a reasonable
period by a subsequent Registration Statement filed with and declared effective
by the Commission, or (iv) the Company suspends the use of the Prospectus
forming a part of such Registration Statement for more than thirty (30) days in
any period of 365 consecutive days if the Company suspends in reliance on its
ability to do so due to the existence of a development that, in the good faith
discretion of the Board, makes it appropriate to so suspend or which renders the
Company unable to comply with the Commission requirements, or the Company
suspends the use of the Prospectus forming a part of such Registration Statement
for more than sixty (60) days in any period of 365 consecutive days for any
other reason, or (v) during the Effectiveness Period, trading in the Common
Stock shall be suspended for any reason for more than three (3) consecutive
Business Days, or (vi) the Company has breached Section 3(m) of this Agreement
(any such failure or breach being referred to as an "Event"), the Company shall
pay as liquidated damages for such failure or breach and not as a penalty (the
"Liquidated Damages") to the Holder (or to its assignees, as the case may be) an
amount equal to two percent (2%) of the purchase price of the Preferred Stock
and the Warrants paid by the initial Holder pursuant to the Purchase Agreement
for each thirty (30) day period, pro rated for any period less than thirty (30)
days, following the Event until the applicable Event has been cured. Payments to
be made pursuant to this Section 8(d) shall be due and payable in cash in
arrears at the end of each thirty (30) day period. The parties agree that the
Liquidated Damages represent a reasonable estimate on the part of the parties,
as of the date of this Agreement, of the amount of damages that may be incurred
by the Holder if the Registration Statement is not filed on or prior to the
Required Filing Date or has not been declared effective by the Commission on or
prior to the Effectiveness Date and maintained in the manner contemplated herein
during the Effectiveness Period or if any other Event as described herein has
occurred.

         (e) Consent to Jurisdiction. The Company and each Purchaser (i) hereby
irrevocably submit to the exclusive jurisdiction of the United States District
Court for the Northern District of Texas and the courts of the State of Texas
located in Dallas County for the purposes of any suit, action or proceeding
arising out of or relating to this Agreement or the Purchase Agreement, (ii)
hereby waive, and agree not to assert in any such suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of such court,
that the suit, action or proceeding is brought in an inconvenient forum or that
the venue of the suit, action or proceeding is improper, and (iii) hereby waive
any and all rights they may have to a trial by jury with respect to any suit,
action or proceeding based on, or arising out of, under, or in connection with,
this Agreement. The Company and each Purchaser consent to process being served
in any such suit, action or proceeding by mailing a copy thereof to such party
at the address in effect for notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice
thereof. Nothing in this Section 8(e) shall affect or limit any right to serve
process in any other manner permitted by law.

                                      -13-

<PAGE>

         (f) Amendments and Waivers. The provisions of this Agreement, including
the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be
given, unless the same shall be in writing and signed by the Company and the
Purchasers.

         (g) Notices. Any notice, demand, request, waiver or other communication
required or permitted to be given hereunder shall be in writing and shall be
effective (i) upon hand delivery by telecopy or facsimile at the address or
number designated below (if delivered on a Business Day during normal business
hours where such notice is to be received), or the first Business Day following
such delivery (if delivered other than on a Business Day during normal business
hours where such notice is to be received), or (ii) on the second Business Day
following the date of mailing by express courier service, fully prepaid,
addressed to such address, or upon actual receipt of such mailing, whichever
shall first occur. The addresses for such communications shall be:

            (x) if to the Company:

                Syntax-Brillian Corporation
                1600 North Desert Drive
                Tempe, Arizona 85281-1230

                Attention:  Vincent F. Sollitto, Jr., Chief Executive Officer
                Telecopier:  (602) 389-8801

             with a copy to:

                Greenberg Traurig, LLP

                2375 East Camelback Road

                Phoenix, Arizona 85016

                Attention:  Robert S. Kant, Esq.
                Telecopier: (602) 445-8100

            (y) if to any Purchaser:

                At the address of such Purchaser set forth on Exhibit A to
                this Agreement.

or to such other address or addresses or facsimile number or numbers as any such
party may most recently have designated in writing to the other parties hereto
by such notice.

         (h) Successors and Assigns. This Agreement shall be binding upon and
inure to the benefit of the parties and their successors and permitted assigns
and shall inure to the benefit of the Holder and its successors and assigns. The
Company may not assign this Agreement or any of its respective rights or
obligations hereunder without the prior written consent of the Purchasers Each
Purchaser may assign its rights hereunder in the manner and to the Persons as
permitted under the Purchase Agreement.

         (i) Assignment of Registration Rights. The rights of the Holder
hereunder, including the right to have the Company register for resale
Registrable Securities in accordance

                                      -14-

<PAGE>

with the terms of this Agreement, shall be assignable by each Holder to any
transferee of the Holder of all or a portion of the shares of Registrable
Securities if: (i) the Holder agrees in writing with the transferee or assignee
to assign such rights, and a copy of such agreement is furnished to the Company
within a reasonable time after such assignment; (ii) the Company is, within a
reasonable time after such transfer or assignment, furnished with written notice
of (A) the name and address of such transferee or assignee, and (B) the
securities with respect to which such registration rights are being transferred
or assigned; (iii) following such transfer or assignment the further disposition
of such securities by the transferee or assignees is restricted under the
Securities Act and applicable state securities laws; (iv) at or before the time
the Company receives the written notice contemplated by clause (ii) of this
Section, the transferee or assignee agrees in writing with the Company to be
bound by all of the provisions of this Agreement; and (v) such transfer shall
have been made in accordance with the applicable requirements of the Purchase
Agreement and shall be for no less than 10% of the Registrable Securities. In
addition, the Holder shall have the right to assign its rights hereunder to any
other Person with the prior written consent of the Company, which consent shall
not be unreasonably withheld, conditioned or delayed. The rights to assignment
shall apply to the Holder (and to subsequent) successors and assigns. In the
event of an assignment pursuant to this Section 8(i), the Purchaser shall pay
all incremental costs and expenses incurred by the Company in connection with
filing a Registration Statement (or an amendment to the Registration Statement)
to register the shares of Registrable Securities assigned to any assignee or
transferee of the Purchaser.

         (j) Counterparts. This Agreement may be executed in any number of
counterparts, each of which when so executed shall be deemed to be an original,
and all of which taken together shall constitute one and the same Agreement. In
the event that any signature is delivered by facsimile transmission, such
signature shall create a valid binding obligation of the party executing (or on
whose behalf such signature is executed) the same with the same force and effect
as if such facsimile signature were the original thereof.

         (k) Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Texas, without regard to principles of
conflicts of law thereof. This Agreement shall not be interpreted or construed
with any presumption against the party causing this Agreement to be drafted.

         (l) Cumulative Remedies. The remedies provided herein are cumulative
and not exclusive of any remedies provided by law.

         (m) Termination. Except as otherwise specifically set forth herein,
this Agreement shall terminate on the earlier to occur of (i) the date on which
all Registrable Securities have been sold pursuant to the Registration
Statement, or (ii) the date on which all remaining Registrable Securities may be
sold without restriction pursuant to Rule 144(k) of the Securities Act.

         (n) Severability. If any term, provision, covenant or restriction of
this Agreement is held to be invalid, illegal, void or unenforceable in any
respect, the remainder of the terms, provisions, covenants and restrictions set
forth herein shall remain in full force and effect and shall in no way be
affected, impaired or invalidated, and the parties hereto shall use their
reasonable efforts to find and employ an alternative means to achieve the same
or substantially the same result as that contemplated by such term, provision,
covenant or

                                      -15-

<PAGE>

restriction. It is hereby stipulated and declared to be the intention of the
parties that they would have executed the remaining terms, provisions, covenants
and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.

         (o) Headings. The headings herein are for convenience only, do not
constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.

      [Remainder of page intentionally left blank. Signature pages to follow.]

                                      -16-

<PAGE>

         IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
duly executed by their respective authorized persons as of the date first
indicated above.

                                            SYNTAX-BRILLIAN CORPORATION

                                            By:      /s/ Wayne A. Pratt
                                               ---------------------------------
                                                     Wayne A. Pratt,
                                                     Chief Financial Officer

               [SIGNATURES OF PURCHASERS TO FOLLOW ON NEXT PAGES.]

<PAGE>

                                   PURCHASERS:

                  GRYPHON MASTER FUND, L.P.

                  By:  Gryphon Partners, L.P., its General Partner

                    By:  Gryphon Management Partners, L.P., its General Partner

                       By:  Gryphon Advisors, L.L.C., its General Partner

                                        By:      /s/ E.B. Lyon, IV
                                            ------------------------------------
                                                 E.B. Lyon, IV, Authorized Agent

                  GSSF MASTER FUND, LP

                  By:  Gryphon Special Situations Fund, LP, its General Partner

                    By:  GSSF Management Partners, LP, its General Partner

                       By:  GSSF, LLC, its General Partner

                                        By:      /s/ E.B. Lyon, IV
                                            ------------------------------------
                                                E.B. Lyon, IV, Authorized Agent

                  [ADDITIONAL PURCHASER SIGNATURE PAGES FOLLOW]

<PAGE>

                           Name of Purchaser: Enable Growth Partners

                                            By: /s/ Mitch Levine
                                               --------------------------------
                                                     Name: Mitch Levine
                                                           --------------------
                                                     Title: Managing Partner
                                                           --------------------

<PAGE>

                           Name of Purchaser: Enable Opportunity Partners

                                            By: /s/ Mitch Levine
                                               ---------------------------------
                                                     Name: Mitch Levine
                                                          ----------------------
                                                     Title: Managing Partner
                                                           ---------------------
<PAGE>

                           Name of Purchaser: Hudson Bay Fund, L.P.

                                            By: /s/ Yoav Roth
                                               ---------------------------------

                                                     Name:  Yoav Roth
                                                          ----------------------
                                                     Title: Portfolio Manager
                                                           ---------------------

<PAGE>

                      Name of Purchaser: DKR SoundShore Oasis Holding Fund Ltd.

                                            By: /s/ Fred Leif
                                               ---------------------------------

                                                     Name: Fred Leif
                                                          ----------------------

                                                     Title: Director
                                                           ---------------------

<PAGE>

                         Name of Purchaser: Castle Creek Technology Partners LLC

                                            By: /s/ Stephen D. Friend
                                               ---------------------------------

                                                     Name: Stephen D. Friend
                                                          ----------------------

                                                     Title: Managing Director
                                                           ---------------------

<PAGE>

                           Name of Purchaser: Bushido Capital Master Fund, LP

                                          By: Bushido Capital Partners, Ltd.,
                                              its General Partner

                                           By: /s/ Christopher Rossman
                                               ----------------------------

                                                     Name: Christopher Rossman
                                                           -------------------

                                                     Title: Managing Director
                                                           -------------------
<PAGE>

                           Name of Purchaser: Nite Capital LP

                                By:      /s/ Keith A. Goodman
                                     -------------------------------------------

                                         Name:    Keith A. Goodman

                                         Title:   Manager of the General Partner

<PAGE>

                           Name of Purchaser: Iroquois Master Fund Ltd.

                                            By: /s/ Joshua Silverman
                                                --------------------------------

                                                     Name: Joshua Silverman
                                                           ---------------------

                                                     Title: Authorized Signatory
                                                            --------------------

<PAGE>

                           Name of Purchaser: Longview Special Finance Inc.

                                            By: /s/ Francois Morax
                                                --------------------------------

                                                     Name: Francois Morax
                                                           ---------------------

                                                     Title: Director
                                                            --------------------

<PAGE>

                           Name of Purchaser: Lagunitas Partners LP

                                            By: /s/ Jon D. Gruber
                                               ---------------------------------
                                                     Name: Gruber & McBaine
                                                           Capital Management
                                                          ----------------------
                                                     Title: General Partner
                                                           ---------------------
<PAGE>

                           Name of Purchaser: Jon D. and Linda W. Gruber Trust

                                            By: /s/ Jon D. Gruber
                                               ---------------------------------
                                                     Name: Jon D. Gruber
                                                          ----------------------
                                                     Title: Trustee
                                                           ---------------------
<PAGE>

                           Name of Purchaser: Gruber & McBaine International

                                            By: /s/ Jon D. Gruber
                                                --------------------------------

                                                     Name: Gruber & McBaine
                                                           Capital Management
                                                          ----------------------

                                                     Title: Investment Adviser
                                                           ---------------------

<PAGE>

                           Name of Purchaser: WesTech Electronics Limited

                                            By: /s/ Tan Chin Hock
                                                --------------------------------

                                                     Name: Tan Chin Hock
                                                          ----------------------

                                                     Title: CFO
                                                           ---------------------

<PAGE>

                                    EXHIBIT A
                                   PURCHASERS

Gryphon Master Fund, L.P.
100 Crescent Court
Suite 490
Dallas, Texas  75201
Fax No.: (214) 871-6711
Attn:  Ryan R. Wolters

With a copy to:

Warren W. Garden, P.C.
100 Crescent Court, Suite 490
Dallas, Texas  75201
Fax No.: (214) 871-6711
Attn:  Warren W. Garden, Esq.

GSSF Master Fund, LP
100 Crescent Court
Suite 475
Dallas, Texas  75201
Fax No.: (214) 871-6711
Attn:  Timothy M. Stobaugh

With a copy to:

Warren W. Garden, P.C.
100 Crescent Court, Suite 490
Dallas, Texas  75201
Fax No.: (214) 871-6711
Attn:  Warren W. Garden, Esq.

Enable Growth Partners
One Ferry Building, Suite 255
San Francisco, CA  94111
Fax: 415-677-1580
Attn: Mitch Levine

Enable Opportunity Partners
One Ferry Building, Suite 255
San Francisco, CA  94111
Fax: 415-677-1580
Attn: Mitch Levine

<PAGE>

Hudson Bay Fund, L.P.
120 Broadway, 40th Floor
New York, NY 10271
Fax no. 212-571-1279
Attn: Yoav Roth, May Lee

DKR SoundShore Oasis Holding Fund Ltd.
c/o DKR Capital Partners L.P.
1281 East Main Street
Stamford, CT 06902
Attn: Rajni A. Narasi
Fax. 203-324-8489

Castle Creek Technology Partners LLC
111 West Jackson Blvd.
20th Floor
Chicago, IL 60604
Fax: (312) 692-7551
Attn: Stephen Friend

Bushido Capital Master Fund, LP
c/o Bushido Capital Partners
275 Seventh Avenue, Suite 2000
New York, NY 10001
Fax No.: (646) 486-6885
Attn.: Christopher Rossman

Nite Capital LP
c/o Nite Capital, LLC
100 E. Cook Ave., Suite 201
Libertyville, IL 60048
Fax 247-968-4648
Attn: Keith Goodman

Iroquois Master Fund Ltd.
641 Lexington Ave., 26th Floor
New York, NY 10022
Attn: Joshua Silverman
Fax: (212) 207-7452

                                      A-2

<PAGE>

Longview Special Finance Inc.
Trident Chambers
PO Box 146
Road Toad, Tortola
British Virgin Islands
Fax: 284-494-3754

Lagunitas Partners LP
c/o Gruber & McBaine Capital Management
50 Osgood Place-PH
San Francisco, CA 94133
Attn: Christine Arroyo
Fax: (415) 956-7858

Jon D. and Linda W. Gruber Trust
c/o Gruber & McBaine Capital Management
50 Osgood Place-PH
San Francisco, CA 94133
Attn: Christine Arroyo
Fax: (415) 956-7858

Gruber & McBaine International
c/o Gruber & McBaine Capital Management
50 Osgood Place-PH
San Francisco, CA 94133
Attn: Christine Arroyo
Fax: (415) 956-7858

WesTech Electronics Limited
No. 34 Kaki Bukit Crescent
Kaki Bukit Teckpark 1
Singapore 416263

                                      A-3

<PAGE>

                                    EXHIBIT B

                              PLAN OF DISTRIBUTION

      We are registering the shares of Common Stock on behalf of the Selling
Stockholders. The Common Stock may be sold in one or more transactions at fixed
prices, at prevailing market prices at the time of sale, at prices related to
the prevailing market prices, at varying prices determined at the time of sale,
or at negotiated prices. A Selling Stockholder may use any one or more of the
following methods when selling shares:

      -     ordinary brokerage transactions and transactions in which the
            broker-dealer solicits purchasers;

      -     block trades in which the broker-dealer will attempt to sell the
            shares as agent but may position and resell a portion of the block
            as principal to facilitate the transaction;

      -     purchases by a broker-dealer as principal and resale by the
            broker-dealer for its account;

      -     an exchange distribution in accordance with the rules of the
            applicable exchange;

      -     privately negotiated transactions;

      -     settlement of short sales entered into after the effective date of
            the registration statement of which this prospectus is a part;

      -     broker-dealers may agree with the Selling Stockholders to sell a
            specified number of such shares at a stipulated price per share;

      -     a combination of any such methods of sale;

      -     through the writing or settlement of options or other hedging
            transactions, whether through an options exchange or otherwise; or

      -     any other method permitted pursuant to applicable law.

      The Selling Stockholders may also sell shares under Rule 144 under the
Securities Act of 1933, as amended (the "Securities Act"), if available, rather
than under this prospectus.

      Broker-dealers engaged by the Selling Stockholders may arrange for other
brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as
agent for the purchaser of shares, from the purchaser) in amounts to be
negotiated, but, except as set forth in a supplement to this Prospectus, in the
case of an agency transaction not in excess of a customary brokerage commission
in compliance with NASDR Rule 2440; and in the case of a principal transaction a
markup or markdown in compliance with NASDR IM-2440.

                                      B-1

<PAGE>

      In connection with the sale of the Common Stock or interests therein, the
Selling Stockholders may enter into hedging transactions with broker-dealers or
other financial institutions, which may in turn engage in short sales of the
Common Stock in the course of hedging the positions they assume. The Selling
Stockholders may also sell shares of the Common Stock short and deliver these
securities to close out their short positions, or loan or pledge the Common
Stock to broker-dealers that in turn may sell these securities. The Selling
Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or the creation of one or more
derivative securities which require the delivery to such broker-dealer or other
financial institution of shares offered by this prospectus, which shares such
broker-dealer or other financial institution may resell pursuant to this
prospectus (as supplemented or amended to reflect such transaction).

      The Selling Stockholders and any broker-dealers or agents that are
involved in selling the shares may be deemed to be "underwriters" within the
meaning of the Securities Act in connection with such sales. In such event, any
commissions received by such broker-dealers or agents and any profit on the
resale of the shares purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act. Each Selling Stockholder has
informed the Company that it does not have any written or oral agreement or
understanding, directly or indirectly, with any person to distribute the Common
Stock. In no event shall any broker-dealer receive fees, commissions and markups
which, in the aggregate, would exceed eight percent (8%).

      The Company is required to pay certain fees and expenses incurred by the
Company incident to the registration of the shares. The Company has agreed to
indemnify the Selling Stockholders against certain losses, claims, damages and
liabilities, including liabilities under the Securities Act.

      Because Selling Stockholders may be deemed to be "underwriters" within the
meaning of the Securities Act, they will be subject to the prospectus delivery
requirements of the Securities Act. In addition, any securities covered by this
prospectus which qualify for sale pursuant to Rule 144 under the Securities Act
may be sold under Rule 144 rather than under this prospectus. Each Selling
Stockholder has advised us that they have not entered into any written or oral
agreements, understandings or arrangements with any underwriter or broker-dealer
regarding the sale of the resale shares. There is no underwriter or coordinating
broker acting in connection with the proposed sale of the resale shares by the
Selling Stockholders.

      We agreed to keep this prospectus effective until the earlier of (i) the
date on which the shares may be resold by the Selling Stockholders without
registration and without regard to any volume limitations by reason of Rule
144(e) under the Securities Act or any other rule of similar effect or (ii) all
of the shares have been sold pursuant to the prospectus or Rule 144 under the
Securities Act or any other rule of similar effect. The resale shares will be
sold only through registered or licensed brokers or dealers if required under
applicable state securities laws. In addition, in certain states, the resale
shares may not be sold unless they have been registered or qualified for sale in
the applicable state or an exemption from the registration or qualification
requirement is available and is complied with.

                                      B-2

<PAGE>

      Under applicable rules and regulations under the Exchange Act, any person
engaged in the distribution of the resale shares may not simultaneously engage
in market making activities with respect to the Common Stock for the applicable
restricted period, as defined in Regulation M, prior to the commencement of the
distribution. In addition, the Selling Stockholders will be subject to
applicable provisions of the Exchange Act and the rules and regulations
thereunder, including Regulation M, which may limit the timing of purchases and
sales of shares of the Common Stock by the Selling Stockholders or any other
person. We will make copies of this prospectus available to the Selling
Stockholders and have informed them of the need to deliver a copy of this
prospectus to each purchaser at or prior to the time of the sale.

                                      B-3

<PAGE>

                                    EXHIBIT C

                         FORM OF NOTICE OF EFFECTIVENESS
                            OF REGISTRATION STATEMENT

[Name and address of Transfer Agent]
___________________
___________________
___________________
Attn:  ____________

                Re:  Syntax-Brillian Corporation

Ladies and Gentlemen:

      We are counsel to Syntax-Brillian Corporation, a Delaware corporation (the
"COMPANY"), and have represented the Company in connection with that certain
Securities Purchase Agreement (the "PURCHASE AGREEMENT"), dated as of December
__, 2005, by and among the Company and the purchasers (the "PURCHASERS" and the
"HOLDERS") named therein pursuant to which the Company issued to the Purchasers
its 6% Redeemable Convertible Preferred Stock and other securities. Pursuant to
the Purchase Agreement, the Company has also entered into a Registration Rights
Agreement with the Purchasers (the "REGISTRATION RIGHTS AGREEMENT"), dated as of
December __, 2005, pursuant to which the Company agreed, among other things, to
register the Registrable Securities (as defined in the Registration Rights
Agreement), under the Securities Act of 1933, as amended (the "1933 ACT"). In
connection with the Company's obligations under the Registration Rights
Agreement, on ___________, 2005, the Company filed a Registration Statement on
Form S-3 (File No. 333-________) (the "REGISTRATION STATEMENT") with the
Securities and Exchange Commission (the "SEC") relating to the resale of the
Registrable Securities which names the Holders as selling stockholders
thereunder.

      In connection with the foregoing, we advise you that a member of the SEC's
staff has advised us by telephone that the SEC has entered an order declaring
the Registration Statement effective under the 1933 Act at [ENTER TIME OF
EFFECTIVENESS] on [ENTER DATE OF EFFECTIVENESS] and we have no knowledge, after
telephonic inquiry of a member of the SEC's staff, that any stop order
suspending its effectiveness has been issued or that any proceedings for that
purpose are pending before, or threatened by, the SEC and, accordingly, the
Registrable Securities are available for resale under the 1933 Act in the manner
specified in, and pursuant to the terms of, the Registration Statement.

                                                     Very truly yours,

                                                     By:

cc:      [PURCHASERS]

                                      C-1

<PAGE>

                                    EXHIBIT D

                                 FORM OF SELLING
                          SECURITYHOLDER QUESTIONNAIRE

                           SYNTAX-BRILLIAN CORPORATION

                      Selling Securityholder Questionnaire

      The undersigned holder of 6% Redeemable Convertible Preferred Stock and
warrants to purchase shares of common stock, par value $0.001 per share (the
"Common Stock"), of Syntax-Brillian Corporation, a Delaware corporation (the
"Company"), (the "Registrable Securities") understands that the Company has
filed or intends to file with the Securities and Exchange Commission (the
"Commission") a registration statement on Form S-3 (the "Registration
Statement") for the registration and resale under Rule 415 of the Securities Act
of 1933, as amended (the "Securities Act"), of the Registrable Securities, in
accordance with the terms of the Registration Rights Agreement, dated as of
December __, 2005 (the "Registration Rights Agreement"), among the Company and
the Purchasers named therein. A copy of the Registration Rights Agreement is
available from the Company upon request at the address set forth below. All
capitalized terms not otherwise defined herein shall have the meanings ascribed
thereto in the Registration Rights Agreement.

      Certain legal consequences arise from being named as a selling
securityholder in the Registration Statement and the related prospectus.
Accordingly, holders and beneficial owners of Registrable Securities are advised
to consult their own securities law counsel regarding the consequences of being
named or not being named as a selling securityholder in the Registration
Statement and the related prospectus.

      The undersigned beneficial owner (the "Selling Securityholder") of
Registrable Securities hereby elects to include the Registrable Securities owned
by it and listed below in Item 3 (unless otherwise specified under such Item 3)
in the Registration Statement.

      The undersigned hereby provides the following information to the Company
and represents and warrants that such information is accurate:

QUESTIONNAIRE

1.    Name.

      (a)   Full Legal Name of Selling Securityholder:

      (b)   Full Legal Name of Registered Holder (if not the same as (a) above)
            through which Registrable Securities listed in Item 3 below are
            held:

                                      D-1

<PAGE>

      (c)   Full Legal Name of Natural Control Person (which means a natural
            person who directly or indirectly alone or with others has power to
            vote or dispose of the securities covered by the questionnaire):

2.    Address for Notices to Selling Securityholder:

             Telephone:
             Fax:
             Contact Person:

3.    Beneficial Ownership of Registrable Securities:

      (a)   Type and Principal Amount of Registrable Securities beneficially
            owned:

4.    Broker-Dealer Status:

      (a)   Are you a broker-dealer?

            [ ]  Yes    [ ]  No

      (b)   If "yes" to Section 4(a), did you receive your Registrable
            Securities as compensation for investment banking services to the
            Company?

            [ ]  Yes    [ ]  No

            Note: If no, the Commission's staff has indicated that you should be
            identified as an underwriter in the Registration Statement.

      (c)   Are you an affiliate of a broker-dealer?

            [ ]  Yes    [ ]  No

                                      D-2

<PAGE>

      (d)   If you are an affiliate of a broker-dealer, do you certify that you
            bought the Registrable Securities in the ordinary course of
            business, and at the time of the purchase of the Registrable
            Securities to be resold, you had no agreements or understandings,
            directly or indirectly, with any person to distribute the
            Registrable Securities?

            [ ]  Yes    [ ]  No

            Note: If no, the Commission's staff has indicated that you should be
            identified as an underwriter in the Registration Statement.

5.    Beneficial Ownership of Other Securities of the Company Owned by the
      Selling Securityholder.

      Except as set forth below in this Item 5, the undersigned is not the
      beneficial or registered owner of any securities of the Company other than
      the Registrable Securities listed above in Item 3.

      (a)   Type and Amount of Other Securities beneficially owned by the
            Selling Securityholder:

6.    Relationships with the Company:

      Except as set forth below, neither the undersigned nor any of its
      affiliates, officers, directors or principal equity holders (owners of 5%
      of more of the equity securities of the undersigned) has held any position
      or office or has had any other material relationship with the Company (or
      its predecessors or affiliates) during the past three years.

      State any exceptions here:

      The undersigned agrees to promptly notify the Company of any inaccuracies
or changes in the information provided herein that may occur subsequent to the
date hereof at any time while the Registration Statement remains effective. By
signing below, the undersigned consents to the disclosure of the information
contained herein in its answers to Items 1 through 6 and the inclusion of such
information in the Registration Statement and the related prospectus and any
amendments or supplements thereto. The undersigned understands that such
information will be relied upon by the Company in connection with the
preparation or amendment of the Registration Statement and the related
prospectus.

                                      D-3

<PAGE>

      IN WITNESS WHEREOF the undersigned, by authority duly given, has caused
this Questionnaire to be executed and delivered either in person or by its duly
authorized agent.

Dated:                                      Beneficial Owner:

                                            By:
                                            Name:
                                            Title:

PLEASE FAX A COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE, AND
RETURN THE ORIGINAL BY OVERNIGHT MAIL, TO:

                           Greenberg Traurig, LLP
                           2375 E. Camelback Road, Suite 700
                           Phoenix, Arizona  85016
                           Attn:  Robert S. Kant
                           Facsimile:  (602) 445-8100

                                      D-4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00095-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00095-of-00352.parquet"}]]